Perez-Brumer, A., Schmidt, R., Kennedy, R., Lake, J. E., Villarreal, Y. R., Bornstein, S., Kuo, I., Nieto, O., Franks, J., Denis, C., El-Bassel, N., Shoptaw, S., Davidson, P., & Smith, L. R. (2024). Centering autonomy and choice to support oral PrEP utilization among people who inject drugs: qualitative lessons from HPTN 094 INTEGRA. Addiction Science & Clinical Practice, 19(1). https://doi.org/10.1186/s13722-024-00520-3

Goddard-Eckrich, D., McCrimmon, T., Bond, K., Chang, M., Hunt, T., Hall, J., Russo, M., Ramesh, V., Johnson, K. A., Downey, D. L., Wu, E., El-Bassel, N., & Gilbert, L. (2024). Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial. Addiction Science & Clinical Practice, 19(1). https://doi.org/10.1186/s13722-024-00488-0

Bartholomew, T. S., Plesons, M., Serota, D. P., Alonso, E., Metsch, L. R., Feaster, D. J., Ucha, J., Suarez, E., Forrest, D. W., Chueng, T. A., Ciraldo, K., Brooks, J., Smith, J. D., Barocas, J. A., & Tookes, H. E. (2024). Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Addiction Science & Clinical Practice, 19(1). https://doi.org/10.1186/s13722-024-00447-9

Xu, K. Y., Gertner, A. K., Greenfield, S. F., Williams, A. R., & Grucza, R. A. (2024). Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims. Addiction Science & Clinical Practice, 19(1). https://doi.org/10.1186/s13722-024-00450-0

Jones-Patten, A., Shin, S. S., Nyamathi, A., & Bounds, D. (2024). “Cigarettes play the equalizer”: discrimination experiences and readiness to quit cigarette smoking among African Americans experiencing homelessness: a qualitative analysis. Addiction Science & Clinical Practice, 19(1). https://doi.org/10.1186/s13722-023-00432-8

Cook, R. R., Foot, C., Arah, O. A., Humphreys, K., Rudolph, K. E., Luo, S. X., Tsui, J. I., Levander, X. A., & Korthuis, P. T. (2023). Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations. Addiction Science & Clinical Practice, 18(1). https://doi.org/10.1186/s13722-023-00364-3

Petrakis, I., Springer, S. A., Davis, C., Ralevski, E., Gu, L., Lew, R., Hermos, J., Nuite, M., Gordon, A. J., Kosten, T. R., Nunes, E. V., Rosenheck, R., Saxon, A. J., Swift, R., Goldberg, A., Ringer, R., & Ferguson, R. (2022). Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans. Addiction Science & Clinical Practice, 17(1). https://doi.org/10.1186/s13722-022-00286-6